Submitted by Anonymous (not verified) on 13 February 2024 - 11:12
Human medicines European public assessment report (EPAR): Incruse Ellipta (previously Incruse), umeclidinium bromide, Date of authorisation: 28/04/2014, Revision: 19, Status: Authorised
Source: